Seagen, A Wholly Owned Subsidiary Of Pfizer
Clinical trials sponsored by Seagen, A Wholly Owned Subsidiary Of Pfizer, explained in plain language.
-
Early trial tests new weapon against Tough-to-Treat blood cancers
Disease control TerminatedThis was an early-stage safety study for an experimental drug called PF-08046045, designed for adults with advanced lymphomas that had stopped responding to other treatments. The main goal was to find a safe dose and understand the drug's side effects. The trial was terminated ea…
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Early cancer drug trial halted after safety testing
Disease control TerminatedThis early-stage study aimed to test the safety and find the right dose of a new drug called Felmetatug Vedotin for people with advanced solid tumors. It was for adults with cancers like ovarian, breast, lung, and others that had spread or could not be removed by surgery. The tri…
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC